Cargando…
Update on Pathogenesis of Glomerular Hyperfiltration in Early Diabetic Kidney Disease
In the existing stages of diabetic kidney disease (DKD), the first stage of DKD is called the preclinical stage, characterized by glomerular hyperfiltration, an abnormally elevated glomerular filtration rate. Glomerular hyperfiltration is an independent risk factor for accelerated deterioration of r...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9161673/ https://www.ncbi.nlm.nih.gov/pubmed/35663316 http://dx.doi.org/10.3389/fendo.2022.872918 |
_version_ | 1784719534881505280 |
---|---|
author | Yang, Yang Xu, Gaosi |
author_facet | Yang, Yang Xu, Gaosi |
author_sort | Yang, Yang |
collection | PubMed |
description | In the existing stages of diabetic kidney disease (DKD), the first stage of DKD is called the preclinical stage, characterized by glomerular hyperfiltration, an abnormally elevated glomerular filtration rate. Glomerular hyperfiltration is an independent risk factor for accelerated deterioration of renal function and progression of nephropathy, which is associated with a high risk for metabolic and cardiovascular disease. It is imperative to understand hyperfiltration and identify potential treatments to delay DKD progress. This paper summarizes the current mechanisms of hyperfiltration in early DKD. We pay close attention to the effect of glucose reabsorption mediated by sodium–glucose cotransporters and renal growth on hyperfiltration in DKD patients, as well as the mechanisms of nitric oxide and adenosine actions on renal afferent arterioles via tubuloglomerular feedback. Furthermore, we also focus on the contribution of the atrial natriuretic peptide, cyclooxygenase, renin–angiotensin–aldosterone system, and endothelin on hyperfiltration. Proposing potential treatments based on these mechanisms may offer new therapeutic opportunities to reduce the renal burden in this population. |
format | Online Article Text |
id | pubmed-9161673 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-91616732022-06-03 Update on Pathogenesis of Glomerular Hyperfiltration in Early Diabetic Kidney Disease Yang, Yang Xu, Gaosi Front Endocrinol (Lausanne) Endocrinology In the existing stages of diabetic kidney disease (DKD), the first stage of DKD is called the preclinical stage, characterized by glomerular hyperfiltration, an abnormally elevated glomerular filtration rate. Glomerular hyperfiltration is an independent risk factor for accelerated deterioration of renal function and progression of nephropathy, which is associated with a high risk for metabolic and cardiovascular disease. It is imperative to understand hyperfiltration and identify potential treatments to delay DKD progress. This paper summarizes the current mechanisms of hyperfiltration in early DKD. We pay close attention to the effect of glucose reabsorption mediated by sodium–glucose cotransporters and renal growth on hyperfiltration in DKD patients, as well as the mechanisms of nitric oxide and adenosine actions on renal afferent arterioles via tubuloglomerular feedback. Furthermore, we also focus on the contribution of the atrial natriuretic peptide, cyclooxygenase, renin–angiotensin–aldosterone system, and endothelin on hyperfiltration. Proposing potential treatments based on these mechanisms may offer new therapeutic opportunities to reduce the renal burden in this population. Frontiers Media S.A. 2022-05-19 /pmc/articles/PMC9161673/ /pubmed/35663316 http://dx.doi.org/10.3389/fendo.2022.872918 Text en Copyright © 2022 Yang and Xu https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Endocrinology Yang, Yang Xu, Gaosi Update on Pathogenesis of Glomerular Hyperfiltration in Early Diabetic Kidney Disease |
title | Update on Pathogenesis of Glomerular Hyperfiltration in Early Diabetic Kidney Disease |
title_full | Update on Pathogenesis of Glomerular Hyperfiltration in Early Diabetic Kidney Disease |
title_fullStr | Update on Pathogenesis of Glomerular Hyperfiltration in Early Diabetic Kidney Disease |
title_full_unstemmed | Update on Pathogenesis of Glomerular Hyperfiltration in Early Diabetic Kidney Disease |
title_short | Update on Pathogenesis of Glomerular Hyperfiltration in Early Diabetic Kidney Disease |
title_sort | update on pathogenesis of glomerular hyperfiltration in early diabetic kidney disease |
topic | Endocrinology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9161673/ https://www.ncbi.nlm.nih.gov/pubmed/35663316 http://dx.doi.org/10.3389/fendo.2022.872918 |
work_keys_str_mv | AT yangyang updateonpathogenesisofglomerularhyperfiltrationinearlydiabetickidneydisease AT xugaosi updateonpathogenesisofglomerularhyperfiltrationinearlydiabetickidneydisease |